글로벌 나르시시즘 약물 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

최근 몇 년 동안, 나르시시즘 약물 시장은 예측 기간 동안 빠르게 성장할 것으로 예상됩니다. 성격 장애 나르시시즘은 10가지 중 하나입니다. 이러한 장애가 있는 사람들은 자신이나 다른 사람에게 해로운 방식으로 생각하고, 느끼고, 행동합니다. 청소년기 후반과 성인 초기에 성격 문제의 징후가 자주 나타납니다. 이와 함께 환경적, 신경생물학적, 유전적 요인이 나르시시즘의 유병률을 증가시키는 다양한 위험 요소입니다. 따라서 시장에서 나르시시즘 약물에 대한 수요가 증가합니다.

Data Bridge Market Research는 2021년 나르시시즘 약물 시장이 5억 7,497만 달러 규모였으며 2029년까지 10억 5,559만 달러에 도달할 것으로 예상하고 2022년부터 2029년까지의 예측 기간 동안 7.89%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

나르시시즘은 사람이 강한 자기 중요성, 관심과 칭찬에 대한 강한 욕구, 다른 사람들이 열등하다는 믿음, 다른 사람들에 대한 공감 부족을 느끼는 성격 장애입니다. 개인적, 사회적, 재정적 상호 작용과 같은 삶의 많은 측면이 나르시시즘의 영향을 받습니다.

보고 범위 및 시장 세분화

Narcissism Drug Market Dynamics

Drivers

• Increasing prevalence of narcissism

The rising prevalence of narcissism is a primary driver of the narcissism drug market's growth. Changing dietary pattern and sedentary lifestyle are the factors that will influence the market dynamics during the forecast period.  

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of narcissism drug market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the narcissism drug market. Additionally, high disposable income and favourable reimbursement scenario will result in the expansion of narcissism drug market. Along with this, rising geriatric population and increasing awareness about narcissism among people will enhance the growth rate of the market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the narcissism drug market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the narcissism drug market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the production as well as distribution of drug will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the narcissism drug market. Additionally, no approved drug for narcissism and the dearth of diagnostic procedures and complex pathophysiology of disorder will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This narcissism drug market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the narcissism drug market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Because identifying narcissistic personality disorder is difficult, there have been conflicting reports of its prevalence in the United States (USA). Community-based prevalence rates have ranged from 0.5 percent to 5% of the US population. NPD, on the other hand, tends to be more common in therapeutic settings. The prevalence percentage in the United States can range from 1% to 15% of the population.

Narcissism drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Narcissism Drug Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations therefore as consequence of multiple precautionary lockdowns and other limitations imposed by governments all over the world. The narcissism drug? market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the narcissism drug market's revenue trajectory.

Global Narcissism Drug Market Scope

The narcissism drug market is segmented on the basis of type, drugs class, treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Classic
• Vulnerable
• Malignant
• Others

On the basis of type, the narcissism drug market is segmented into classic, vulnerable, malignant, and others.

Drugs Class

• Antidepressants
• Antianxiety
• Antipsychotics
• Others

On the basis of drugs class, the narcissism drug market is segmented into antidepressants, antianxiety, antipsychotics, and others.

Treatment

• Medication
• Psychotherapy

On the basis of treatment, the narcissism drug market is segmented into medication, and psychotherapy.

Route of Administration

• Oral
• Intravenous
• Others

On the basis of route of administration, the narcissism drug market is segmented into oral, intravenous, and others.

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

On the basis of end-users, the narcissism drug market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

On the basis of distribution channel, the narcissism drug market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Narcissism Drug Market Regional Analysis/Insights

The Narcissism drug market is analysed and market size insights and trends are provided by country, type, drugs class, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Narcissism drug market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America and Europe dominate the narcissism drug market because of the growing prevalence of narcissism in this region. Additionally, growing focus of major key players on novel technology will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to number of population and rising healthcare expenditure in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

경쟁 환경 및 나르시시즘 약물 시장 점유율 분석

나르시시즘 약물 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 나르시시즘 약물 시장과 관련된 회사의 초점에만 관련이 있습니다.

나르시시즘 약물 시장에서 활동하는 주요 업체는 다음과 같습니다.

• Teva Pharmaceutical Industries Ltd.(예루살렘)
• 사노피(프랑스)
• 노바티스 AG(스위스)
• 엘리 릴리 앤드 컴퍼니(미국)
• 머크앤코(미국)
• 아스트라제네카(영국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• 베링거 인겔하임 인터내셔널 GmbH. (독일)
• 메드트로닉(아일랜드)
• 브리스톨-마이어스 스퀴브 회사(미국)
• 애벗(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• AbbVie Inc.(미국)
• 오츠카 아메리카 제약 주식회사(미국)
• 다케다제약 주식회사(일본)
• 파이저 주식회사(미국)
• GlaxoSmithKline plc (영국)
• 머크 KGaA(독일)
• H. Lundbeck A/S(덴마크)
• 알러간(아일랜드)   

SKU-46073